KR20100133980A - 안약 조성물 - Google Patents

안약 조성물 Download PDF

Info

Publication number
KR20100133980A
KR20100133980A KR1020107020628A KR20107020628A KR20100133980A KR 20100133980 A KR20100133980 A KR 20100133980A KR 1020107020628 A KR1020107020628 A KR 1020107020628A KR 20107020628 A KR20107020628 A KR 20107020628A KR 20100133980 A KR20100133980 A KR 20100133980A
Authority
KR
South Korea
Prior art keywords
composition
cps
viscosity
ophthalmic composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020107020628A
Other languages
English (en)
Korean (ko)
Inventor
아린담 홀더
아제이 제이싱 코파데
서브하스 발라람 보우믹
Original Assignee
썬 파마 어드밴스트 리서치 컴패니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 썬 파마 어드밴스트 리서치 컴패니 리미티드 filed Critical 썬 파마 어드밴스트 리서치 컴패니 리미티드
Publication of KR20100133980A publication Critical patent/KR20100133980A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020107020628A 2008-03-07 2009-03-09 안약 조성물 Withdrawn KR20100133980A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN477MU2008 2008-03-07
IN477/MUM/2008 2008-03-07

Publications (1)

Publication Number Publication Date
KR20100133980A true KR20100133980A (ko) 2010-12-22

Family

ID=41056432

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107020628A Withdrawn KR20100133980A (ko) 2008-03-07 2009-03-09 안약 조성물

Country Status (9)

Country Link
US (1) US20110003816A1 (enExample)
EP (1) EP2249871A4 (enExample)
JP (1) JP2011513393A (enExample)
KR (1) KR20100133980A (enExample)
CN (1) CN101977630B (enExample)
BR (1) BRPI0909797A2 (enExample)
CA (1) CA2717825A1 (enExample)
MX (1) MX2010009857A (enExample)
WO (1) WO2009110009A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2837240A1 (en) * 2011-05-27 2012-12-06 Ratiopharm Gmbh Ophthalmic preparation comprising a pgf2.alpha. analogue
JP6260230B2 (ja) 2013-11-28 2018-01-17 ライオン株式会社 眼科用組成物
EP2979689A1 (en) * 2014-07-29 2016-02-03 Sygene Technologies Composition for an eye drop and delivery system therefor
CN106619573B (zh) * 2016-12-27 2019-09-20 广州中大南沙科技创新产业园有限公司 马来酸噻吗洛尔立方液晶纳米粒滴眼液及其制备方法
DE102017103346A1 (de) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
US20210000844A1 (en) * 2018-02-28 2021-01-07 Santen Pharmaceutical Co., Ltd. Ophthalmic composition comprising diquafosol and cationic polymer
WO2020050423A1 (ja) 2018-09-07 2020-03-12 株式会社ファルネックス 非ラメラ液晶形成脂質を含む外用剤
US20240390416A1 (en) * 2021-09-30 2024-11-28 Rohto Pharmaceutical Co., Ltd. Ophthalmological composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
ATE141502T1 (de) * 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
JP2719049B2 (ja) * 1991-01-28 1998-02-25 日本碍子株式会社 ランタンクロマイト膜の製造方法及び固体電解質型燃料電池用インターコネクターの製造方法
SE512871C2 (sv) * 1992-08-20 2000-05-29 Santen Oy Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US6335335B2 (en) * 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
US6174524B1 (en) * 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
TR200302008T4 (tr) * 1999-11-30 2004-01-21 Alcon, Inc. Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı.
CA2396524C (en) * 1999-12-27 2010-08-03 Santen Pharmaceutical Co., Ltd. System for stabilizing lacrimal fluid layer
WO2004103373A1 (ja) * 2003-05-23 2004-12-02 Santen Pharmaceutical Co.,Ltd. キノロン系抗菌化合物を含有する点眼液
US7063862B2 (en) * 2003-06-03 2006-06-20 Biokey, Inc. Pharmaceutical composition and method for treating
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
JP4860475B2 (ja) * 2003-06-13 2012-01-25 アルコン，インコーポレイテッド ２種のポリマーの相乗作用的組み合わせを含む眼科用組成物
US6960300B2 (en) * 2003-09-08 2005-11-01 Sami Labs Limited Process for preparing water soluble diterpenes and their applications
US20060292101A1 (en) * 2005-06-28 2006-12-28 Roya Borazjani In-eye method of cleaning and/or disinfecting silicone hydrogel contact lenses

Also Published As

Publication number Publication date
WO2009110009A3 (en) 2009-12-23
EP2249871A2 (en) 2010-11-17
CN101977630A (zh) 2011-02-16
CA2717825A1 (en) 2009-09-11
US20110003816A1 (en) 2011-01-06
EP2249871A4 (en) 2011-03-16
CN101977630B (zh) 2012-11-21
WO2009110009A2 (en) 2009-09-11
JP2011513393A (ja) 2011-04-28
BRPI0909797A2 (pt) 2017-08-22
MX2010009857A (es) 2010-12-07

Similar Documents

Publication Publication Date Title
US11931359B2 (en) Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
AU694498B2 (en) Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
KR20100133980A (ko) 안약 조성물
CN103501771B (zh) 用于上睑下垂的非手术治疗的组合物和方法
NO313861B1 (no) Flytende oftalmisk avleveringssystem med langvarig frigjöring og fremgangsmÕte for fremstilling derav
SA521430043B1 (ar) صياغات من المركب 4-(7- هيدروكسي-2- أيزوبروبيل-4- أوكسو-4h- كوينازولين-3- يل) - بنزونيتريل
WO2017066052A1 (en) Formulations and methods for treating high intraocular pressure
JP2023530188A (ja) 高分子量ヒアルロン酸の眼科用薬物輸送ビヒクルとしての使用
JP2023099870A (ja) 眼科用清涼組成物
RU2670100C2 (ru) Офтальмическая композиция для цвиттерионных мягких контактных линз
JP5403850B2 (ja) 眼科用清涼組成物
RU2710366C1 (ru) Термочувствительная гелеобразующая искусственная слеза
KR102268002B1 (ko) 효과 지속성 점안제 조성물
Halder et al. A gel-free reservoir system for once-a-day ophthalmic delivery of Timolol maleate
EP4454639A1 (en) Ophthalmic composition comprising carbomer and taurine
CA3204243A1 (en) Method of reducing elevated intraocular pressure
JP2024177323A (ja) 眼圧下降用組成物
GUPTA STUDIES ON IN SITU GELLING SYSTEM FOR BETTER OCULAR DRUG THERAPY

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100915

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid